SEC Form 4 · accession 0001140361-16-076926
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Monty K Allen
Director
Period of report
Aug 15, 2016
Accepted (ET)
Aug 16, 2016 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2016 | A | 2,500 | $1.48 | A | 4,775 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.48 | Aug 15, 2016 | M | 2,500 | D | — | Dec 30, 2023 | Common Stock | 2,500 | 13,125 | D |
Explanation of responses
- F1This option, representing a right to purchase a total of 26,250 shares, was granted on 1/1/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.